These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8437759)

  • 1. Control of emesis associated with cancer chemotherapy.
    Robinson B
    N Z Med J; 1993 Feb; 106(950):52-4. PubMed ID: 8437759
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of serotonin antagonists for the control of chemotherapy-induced emesis.
    Hainsworth JD
    Semin Surg Oncol; 1993; 9(3):279-84. PubMed ID: 8516617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New agents for controlling emesis with cancer chemotherapy.
    Gralla RJ; Clark RA
    J La State Med Soc; 1993 Apr; 145(4):169-73. PubMed ID: 8486990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT3-receptor antagonists in the control of delayed-onset emesis.
    Gridelli C
    Anticancer Res; 2003; 23(3C):2773-82. PubMed ID: 12926112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy.
    Cunningham RS
    Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):33-40. PubMed ID: 9282379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nausea and vomiting in oncologic therapy. Guidelines for use of setrone].
    Nemec K
    Pharm Unserer Zeit; 2007; 36(5):362-7. PubMed ID: 17722163
    [No Abstract]   [Full Text] [Related]  

  • 9. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice.
    Antonarakis ES; Hain RD
    Arch Dis Child; 2004 Sep; 89(9):877-80. PubMed ID: 15321871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nurses and emesis induced by cancer therapy.
    Dulfer S
    Nurs RSA; 1991 Mar; 6(3):9-11, 14. PubMed ID: 2046739
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?
    de Wit R; Aapro M; Blower PR
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):231-8. PubMed ID: 15838653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of 5-HT3 receptor antagonists: clinical overview and nursing implications.
    Bremerkamp M
    Clin J Oncol Nurs; 2000; 4(5):201-7. PubMed ID: 11111451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced nausea and vomiting.
    Lohr L
    Cancer J; 2008; 14(2):85-93. PubMed ID: 18391612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and management of nausea and emesis.
    Dicato M
    Oncology; 1996 Jun; 53 Suppl 1():1-3. PubMed ID: 8692544
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of dexamethasone with 5-HT3-receptor antagonists for chemotherapy-induced nausea and vomiting.
    Perez EA
    Cancer J Sci Am; 1998; 4(2):72-7. PubMed ID: 9532406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.
    Mahesh R; Perumal RV; Pandi PV
    Pharmazie; 2005 Feb; 60(2):83-96. PubMed ID: 15739895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of emesis by tropisetron (Navoban) in children receiving cytotoxic therapy for solid malignancies.
    Otten J; Hachimi-Idrissi S; Balduck N; Maurus R
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):17-9. PubMed ID: 9113122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents?
    Aapro M; Blower P
    Cancer; 2005 Jul; 104(1):1-18. PubMed ID: 15929119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granisetron: is there a dose-response effect on nausea and vomiting?
    Minami M
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):89-98. PubMed ID: 12783208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.